Summary
The interaction of clorgyline andl-deprenil with the-A and-B forms of human brain monoamine oxidase (MAO) has been studied. Both compounds inhibit cerebrocortical MAO in a manner consistent with a ‘suicide’ inactivation of the enzyme. The interaction of clorgyline with the-A form of the enzyme appears to take place almost entirely at specific binding sites, and the conditions required for this inhibitor to ‘titrate’ the concentrations of MAO-A have been elucidated.l-Deprenil has also been used to titrate the concentration of the-B form of MAO in cerebrocortical homogenates, but there is a considerable degree of non-specific binding of this compound. The two inhibitors have been used to titrate the concentrations of the two enzyme forms in frontal cortex homogenates from different age groups. There was a significantly higher MAO-B activity for the age range 73–95 years than for the age range 2–63 years. No significant differences between the two age groups were found for MAO-A. The activity of MAO-A in the samples correlated very well with the concentration of this enzyme form. Titration of the B-form of the enzyme withl-deprenil indicated an increased enzyme concentration with age, although other factors, such as the non-specific binding of this compound, could contribute to this effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Buffoni, F., Ignesti, G., Pirisino, R., Cortesini, C.: Platelet monoamine oxidase, plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients. Med. Biol.55, 109–111 (1977)
Callingham, B. A., Laverty, R.: Studies on the nature of the increasing monoamine oxidase activity in the rat heart after adrenalectomy. J. Pharm. Pharmacol.25, 940–947 (1973)
Eckert, B., Gottfries, C.-G., von Knorring, L., Oreland, L., Wiberg, Å., Winblad, B.: Brain and platelet monoamine oxidase in schizophrenics and cycloid psychotics. Progr. Neuropsychopharmacol. (in press, 1980)
Egashira, T., Ekstedt, B., Oreland, L.: Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. Biochem. Pharmacol.25, 2583–2586 (1976a)
Egashira, T., Ekstedt, B., Kinemuchi, H., Wiberg, Å., Oreland, L.: Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat. Med. Biol.54, 272–277 (1976b)
Fowler, C. J.: Monoamine oxidase in the chick and rat. PhD Thesis, University of Cambridge 1978
Fowler, C. J., Callingham, B. A.: The inhibition by clorgyline of 5-hydroxytryptamine deamination in the rat liver. J. Pharm. Pharmacol.30, 304–309 (1978)
Fowler, C. J., Callingham, B. A.: The inhibition of rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centres. Mol. Pharmacol.16, 546–555 (1979)
Fowler, C. J., Oreland, L.: Substrate-selective interaction between monoamine oxidase and oxygen. In: Monoamine oxidase; structure, function and altered functions, (T. P. Singer, R. W. Von Korff, D. L. Murphy, eds.), pp. 145–151. New York: Academic Press 1979
Fowler, C. J., Callingham, B. A., Mantle, T. J., Tipton, K. F.: Monoamine oxidase A and B: a useful concept? Biochem. Pharmacol.27, 97–101 (1978)
Fowler, C. J., Ekstedt, B., Egashira, T., Kinemuchi, H., Oreland, L.: The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem. Pharmacol.28, 3063–3068 (1979a)
Fowler, C. J., Oreland, L., Wiberg, Å., Carlsson, A., Magnusson, T.: The inhibition of rat brain monoamine oxidase-B by J-508 [N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride], and its use for the titration of this enzyme form. Med. Biol.57, 406–411 (1979b)
Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B.: Brain levels of monoamine oxidase in depression. Lancet1974II, 360–361
Gottfries, C.-G., Oreland, L., Wiberg, Å., Winblad, B.: Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem.25, 667–673 (1975)
Gripois, D.: Developmental characteristics of monoamine oxidase. Comp. Biochem. Physiol.51C, 143–151 (1975)
Grote, S. S., Moses, S. G., Robins, E., Hudgens, R. W., Croninger, A. B.: A study of selected catecholamine metabolising enzymes: a comparison of depressive suicides and alcoholic suicides with controls. J. Neurochem.23, 791–802 (1974)
Grufferman, S.: Alzheimer's disease and senile dementia: one disease or two? In: Alzheimer's disease: Senile dementia and related disorders. Aging. Vol. 7 (R. Katzman, R. D. Terry, K. L. Bick, eds.), pp. 35–41, New York: Raven Press 1978
Hall, D. W. R., Logan, B. W., Parsons, G. H.: Further studies on the inhibition of monoamine oxidase by M&B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem. Pharmacol.18, 1447–1454 (1969)
Hellerman, L., Erwin, V. G.: Mitochondrial monoamine oxidase. II. Action of various inhibitors for the bovine kidney enzyme. Catalytic mechanism. J. Biol. Chem.243, 5234–5243 (1968)
Jain, M., Sands, F., Von Korff, R. W.: Monoamine oxidase activity measurements using radioactive substrates. Anal. Biochem.52, 542–554 (1973)
Johnston, J. P.: Some observations on a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol.17, 1285–1297 (1968)
Knoll, J., Magyar, K.: Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol.5, 393–408 (1972)
Mackay, A. V. P., Davies, P., Dewar, A. J., Yates, C. M.: Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J. Neurochem.30, 827–839 (1978)
Mantle, T. J., Garrett, N. J., Tipton, K. F.: The development of monoamine oxidase in rat liver and brain. FEBS Lett.64, 227–230 (1976)
Markwell, M. A. K., Haas, S. M., Bieber, L. L., Tolbert, N. E.: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem.87, 206–210 (1978)
Maycock, A. L., Abeles, R. H., Salach, J. I., Singer, T. P.: The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavin of mitochondrial monoamine oxidase. Biochemistry15, 114–125 (1976)
Nies, A., Robinson, D. S., Davis, J. M., Ravaris, C. L.: Changes in monoamine oxidase with aging. In: Psychopharmacology and aging. Advances in behavioural biology, Vol. 6 (C. Eisdorfer, W. E. Fann, eds.), pp. 41–54. New York and London: Plenum Press 1973
Oreland, L.: The activity of human brain and thrombocyte monoamine oxidase (MAO) in relation to some psychiatric disorders. I. MAO activity in some disease states. In: Monoamine oxidase; structure, function and altered functions (T. P. Singer, R. W. Von Korff, D. L. Murphy, eds.), pp. 379–387, New York: Academic Press 1979
Oreland, L., Fowler, C. J.: The activity of human brain and thrombocyte monoamine oxidase (MAO) in relation to some psychiatric disorders. II. The nature of the changed MAO activity. In: Monoamine oxidase; structure, function and altered functions (T. P. Singer, R. W. Von Korff, D. L. Murphy, eds.), pp. 389–396, New York: Academic Press 1979
Oreland, L., Kinemuchi, H., Yoo, B. Y.: The mechanism of action of the monoamine oxidase inhibitor pargyline. Life Sci.13, 1533–1541 (1973)
Rando, R. R.: Chemistry and enzymology of kcat inhibitors. Science185, 320–324 (1974)
Robinson, D. S.: Changes in monoamine oxidase and monoamines with human development and aging. Fed. Proc.34, 103–107 (1975)
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L., Sylwester, D.: Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets. Arch. Gen. Psychiat.24, 536–539 (1971)
Robinson, D. S., Sourkes, T. L., Nies, A., Harris, L. S., Spector, S., Bartlett, D. L., Kaye, L. S.: Monoamine metabolism in human brain. Arch. Gen. Psychiat.34, 89–92 (1977)
Roth, J. A.: Evidence for a single catalytic binding site on human brain type B monoamine oxidase. J. Neurochem.27, 1107–1112 (1976)
Shih, J.: Monoamine oxidase in aging human brain. In: Monoamine oxidase; structure, function and altered functions (T. P. Singer, R. W. Von Korff, D. L. Murphy, eds.), pp. 413–421, New York: Academic Press 1979
Tipton, K. F., Youdim, M. B. H.: Assay of monoamine oxidase. In: Monoamine oxidase and its inhibition. Ciba foundation symposium 39 (G. E. W. Wolstenholme, J. Knight, eds.), pp. 393–403. Amsterdam: Elsevier, Exerpta Medica, North Holland 1976
Tipton, K. F., Houslay, M. D., Garrett, N. J.: Allotopic properties of human brain monoamine oxidase. Nature New Biol. (Lond.)246, 213–214 (1973)
Tipton, K. F., Houslay, M. D., Turner, A. J.: Metabolism of aldehydes in brain. Essays Neurochem. Neuropharmacol.1, 103–138 (1977)
White, H. L., Glassman, A. T.: Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitors, and attempts to separate enzyme forms. J. Neurochem.29, 987–997 (1977)
Wiberg, Å., Oreland, L.: Quantitative aspects on mitochondrial monoamine oxidase in human platelets. Med. Biol.54, 137–141 (1976)
Youdim, M. B. H.: Rat liver mitochondrial monoamine oxidase — an iron requiring flavoprotein. In: Flavins and flavoproteins (T. P. Singer, ed.), pp. 593–604. Amsterdam, London, New York: Elsevier 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fowler, C.J., Oreland, L., Marcusson, J. et al. Titration of human brain monoamine oxidase-A and-B by clorgyline andl-deprenil. Naunyn-Schmiedeberg's Arch. Pharmacol. 311, 263–272 (1980). https://doi.org/10.1007/BF00569406
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00569406